Skip to Main Content

Author Details

Michael Nekorchuk
Vaccine & Gene Therapy Institute, Oregon Health & Science University
2007
22
13
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36989320Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.PLoS Pathog2023
34985671In Situ Multiplexing to Identify, Quantify, and Phenotype the HIV-1/SIV Reservoir Within Lymphoid Tissue.Methods Mol Biol2022
35856680Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Fibrosis in the Spleens of Nonhuman Primates.Antimicrob Agents Chemother2022
35395058Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.PLoS Pathog2022
35714200Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.Sci Immunol2022
35447093Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments.Immunity2022
33278358Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.Cell2021
33536176Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>.J Virol2021
33782003Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Collagen in the Mesenteric Lymph Nodes of Nonhuman Primates.Antimicrob Agents Chemother2021
33630764CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.J Clin Invest2021
34039843Eliminating HIV reservoirs for a cure: the issue is in the tissue.Curr Opin HIV AIDS2021
32434946SARS-CoV-2 infection protects against rechallenge in rhesus macaques.Science2020
32884153Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.Nat Med2020
32284611CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.Nat Med2020
31300344TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.EBioMedicine2019
24719410Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.J Virol2014
23849790The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.Virology2013
24245672HIV relies on neddylation for ubiquitin ligase-mediated functions.Retrovirology2013
22292079The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.PLoS One2012
23043097Retention in endoplasmic reticulum 1 (RER1) modulates amyloid-β (Aβ) production by altering trafficking of γ-secretase and amyloid precursor protein (APP).J Biol Chem2012
21041720CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.J Immunol2010
17609285Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export.J Virol2007
  • 1 - 22 of 22

Recommended Authors

California State University Long Beach
Career Start Year 2014
Number of shared co-authors 1
University Hospital of Wurzburg
Career Start Year 2012
Number of shared co-authors 1
Rush University Medical Center
Career Start Year 2011
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Gladstone Institutes
Career Start Year 2010
Number of shared co-authors 6
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year 2009
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 12
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 1
Noguchi Memorial Institute for Medical Research, University of Ghana
Career Start Year 2004
Number of shared co-authors 1
Graduate School of Medicine, Kyoto University
Career Start Year 2004
Number of shared co-authors 5
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 2
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 2
University of California davis
Career Start Year 2002
Number of shared co-authors 3
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 2
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
University College London
Career Start Year 1995
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 2
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 3
University of Utah
Career Start Year 1991
Number of shared co-authors 5
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 1
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 6
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 7
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 5

Collaborators

Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 15
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 7
Frederick National Laboratory
Co-authored papers 4
Co-authored papers 3
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Vaccine and Gene Therapy Institute and.
Co-authored papers 2
Vaccine & Gene Therapy Institute, and Oregon National Primate Research Center
Co-authored papers 2
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
The Wistar Institute
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 1
AMO Pharma Ltd.
Co-authored papers 1
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Emory Center for Neurodegenerative Disease
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
College of Medicine, University of Florida
Co-authored papers 1
Institute for Translational HIV Research, University Hospital Essen
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 1